State Street Corp Poseida Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,710,565 shares of PSTX stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,710,565

Previous 1,671,795 2.32%

Holding current value

$16.3 Million

Previous $4.88 Million 0.23%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.7 - $4.04 $104,679 - $156,630	38,770 Added 2.32%	1,710,565 $4.89 Million
Q2 2024 Aug 14, 2024	BUY	$2.0 - $3.46 $441,628 - $764,016	220,814 Added 15.22%	1,671,795 $4.88 Million
Q1 2024 May 15, 2024	BUY	$2.76 - $4.13 $197,235 - $295,138	71,462 Added 5.18%	1,450,981 $4.63 Million
Q4 2023 Feb 14, 2024	BUY	$1.83 - $3.51 $278,714 - $534,583	152,303 Added 12.41%	1,379,519 $4.64 Million
Q3 2023 Nov 14, 2023	BUY	$1.62 - $2.79 $175,706 - $302,606	108,461 Added 9.69%	1,227,216 $2.92 Million
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.4 $1.47 Million - $3.01 Million	884,288 Added 377.15%	1,118,755 $1.97 Million
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $236,852 - $671,337	76,900 Added 48.8%	234,467 $722,000
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $215,118 - $412,148	64,600 Added 69.49%	157,567 $835,000
Q2 2022 Aug 15, 2022	SELL	$1.87 - $5.0 $820,193 - $2.19 Million	-438,606 Reduced 82.51%	92,967 $240,000
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $39,795 - $87,007	-12,359 Reduced 2.27%	531,573 $2.38 Million
Q4 2021 Feb 14, 2022	BUY	$6.23 - $7.6 $139,670 - $170,384	22,419 Added 4.3%	543,932 $3.7 Million
Q3 2021 Nov 15, 2021	BUY	$7.09 - $10.71 $53,323 - $80,549	7,521 Added 1.46%	521,513 $3.8 Million
Q2 2021 Aug 16, 2021	BUY	$7.96 - $10.07 $496,019 - $627,501	62,314 Added 13.8%	513,992 $5.15 Million
Q1 2021 May 17, 2021	BUY	$8.51 - $11.91 $2.25 Million - $3.15 Million	264,879 Added 141.8%	451,678 $4.31 Million
Q4 2020 Feb 16, 2021	BUY	$8.29 - $11.7 $457,201 - $645,266	55,151 Added 41.89%	186,799 $2.05 Million
Q3 2020 Nov 10, 2020	BUY	$8.09 - $16.25 $1.07 Million - $2.14 Million	131,648 New	131,648 $1.17 Million

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $816M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Poseida Therapeutics, Inc. Transaction History